Why the study?
Hemorrhagic transformation after AF-related stroke can delay oral anticoagulation initiation, prompting investigation into whether white matter disease presence and severity affect early hemorrhagic transformation.
Does the severity of white matter disease predict early hemorrhagic transformation in patients with acute ischemic stroke related to atrial fibrillation?
Does the severity of white matter disease predict early hemorrhagic transformation in patients with acute ischemic stroke related to atrial fibrillation?
The severity of white matter disease is an independent radiological predictor of early hemorrhagic transformation in patients with atrial fibrillation-related acute ischemic stroke.
WMD severity may flag higher early HT risk in AF stroke; leaves open whether it should guide anticoagulation timing.
BACKGROUND: Hemorrhagic transformation (HT) after stroke, related to atrial fibrillation (AF), is a frequent complication, and it can be associated with a delay in the (re-)initiation of oral anticoagulation therapy. We investigated the effect of the presence and severity of white matter disease (WMD) on early HT after stroke related to AF. METHODS: A consecutive series of patients with recent (<4 weeks) ischemic stroke and AF, treated at the Hyper Acute Stroke Unit of the Imperial College London between 2010 and 2017, were enrolled. Patients with brain MRI performed 24-72 h from stroke onset and not yet started on anticoagulant treatment were included. WMD was graded using the Fazekas score. RESULTS: Among the 441 patients eligible for the analysis, 91 (20.6%) had any HT. Patients with and without HT showed similar clinical characteristics. Patients with HT had a larger diffusion-weighted imaging (DWI) infarct volume compared to patients without HT (p < .001) and significant difference in the distribution of the Fazekas score (p = .001). On multivariable analysis, HT was independently associated with increasing DWI infarct volume (odd ratio (OR), 1.03; 95% confidence interval (CI), 1.01-1.05; p < .001), higher Fazekas scores (OR, 1.94; 95% CI, 1.47-2.57; p < .001) and history of previous intracranial hemorrhage (OR, 4.80; 95% CI, 1.11-20.80; p = .036). CONCLUSIONS: Presence and severity of WMD is associated with increased risk of development of early HT in patients with stroke and AF. Further evidence is needed to provide reliable radiological predictors of the risk of HT in cardioembolic stroke.
No takes yet. Share an insight, caveat, or question.
D’Anna et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: